Repurposed drug may boost liver transplant success
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
An existing drug could protect donor livers from damage during the transplantation process and reduce complications that occur afterwards, a study suggests.
Dec 21, 2022
0
31
A researcher at the University of Houston College of Pharmacy is reporting an effective protocol for reprogramming human heart cells into specialized cells that conduct electricity throughout the heart to enable rhythmic ...
Nov 21, 2022
0
77
Intestinal bacteria composition is crucial to driving the recovery of neutrophil counts in the blood of mice following treatments such as stem cell transplants or chemotherapy.
Nov 21, 2022
0
63
Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University of Zurich has now examined in detail the way in which the treatment curbs the autoimmune disease ...
Nov 10, 2022
0
79
A fault in cells that form a key part of the immune system can be repaired with a pioneering gene editing technique, finds new research demonstrated in human cells and mice, led by UCL scientists.
Oct 26, 2022
0
67
More than half of the most seriously affected type 1 diabetes patients achieved years of insulin independence after they received a new method of islet cell transplantation, according to a paper published in Diabetes Care ...
Oct 17, 2022
0
1448
Organ damage occurs in up to 70% of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.
Oct 13, 2022
0
40
Patients who receive organ transplants must take powerful medications to prevent the immune system from rejecting the organ. Unfortunately, these drugs can cause a host of serious side effects and increase the risk of infections ...
Sep 26, 2022
0
15
UCLA researchers report a step forward in the development of an "off-the-shelf" cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment ...
Sep 6, 2022
0
57
Although there has been significant progress in the treatment of rare forms of blood cancer in recent years and new drugs have been approved in Germany, the prognosis for many affected individuals remains unfavorable. Research ...
Aug 5, 2022
0
57